Univariate regression | Multivariate regression | |||
---|---|---|---|---|
OR (95% CI) | p Value | OR (95% CI) | p Value | |
URTI or GE | 14.00 (1.84 to 106.46) | 0.011 | 37.18 (1.91 to 724.99) | 0.017 |
Heart disease* | 2.20 (0.76 to 6.33) | 0.144 | 2.48 (0.63 to 9.80) | 0.195 |
Hypertension | 1.00 (0.35 to 2.85) | 1.000 | ||
Dyslipidaemia | 2.57 (1.07 to 6.16) | 0.034 | 2.46 (0.59 to 10.31) | 0.218 |
Diabetes | 1.75 (0.51 to 5.98) | 0.372 | ||
Smoking | 1.83 (0.68 to 5.00) | 0.350 | ||
Obesity | 1.67 (0.40 to 6.97) | 0.484 | ||
Antiplatelet therapy | 1.50 (0.42 to 5.32) | 0.530 | ||
Tachycardia | 0.42 (0.15 to 1.18) | 0.100 | 0.45 (0.89 to 2.34) | 0.345 |
High WCC | 0.80 (0.37 to 1.71) | 0.565 |
Clinical correlates with p<0.2 underwent multivariate analysis.
*Defined as valvular and/or ischaemic heart disease.
Antiplatelet therapy, aspirin and/or clopidogrel; GE, gastroenteritis; obesity, body mass index ≥30 kg/m2; tachycardia, heart rate >100 bpm; URTI, upper respiratory tract infection; High WCC, white cell count >9.8 G/L.